TVM Capital

Type

Venture Capital

Status

Active

Location

Munich, Germany

Total investments

102

Average round size

19M

Portfolio companies

55

Rounds per year

2.55

Lead investments

13

Follow on index

0.46

Exits

32

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHealth DiagnosticsManufacturingMedicalPharmaceuticalTherapeuticsWireless

Summary

TVM Capital is the famous VC, which was founded in 1983. The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Munich.

The important activity for fund was in 2007. The typical startup value when the investment from TVM Capital is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this TVM Capital performs on 0 percentage points more the average number of lead investments. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2014.

This organization was formed by Rolf Christof Dienst. We also calculated 6 valuable employees in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vivoryon Therapeutics, Rapid Micro Biosystems, VPIsystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Pharmaceutical, Manufacturing.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the TVM Capital, startups are often financed by Atlas Venture, Crescendo Ventures, 3i Group. The meaningful sponsors for the fund in investment in the same round are Skyline Ventures, Atlas Venture, Next47. In the next rounds fund is usually obtained by Skyline Ventures, Longitude Capital, Intersouth Partners.

Show more

Investor highlights

Industry focus
MedtechHealthcare
Stage focus
Series DSeries ASeries ESeries FSeries B Show 1 more
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 51 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 250000000
Fund raised date
2024-05-28

Analytics

Total investments
102
Lead investments
13
Exits
32
Rounds per year
2.55
Follow on index
0.46
Investments by industry
  • Biotechnology (57)
  • Health Care (30)
  • Pharmaceutical (27)
  • Software (20)
  • Medical (16)
  • Show 50 more
Investments by region
  • United States (57)
  • Germany (21)
  • United Kingdom (10)
  • France (2)
  • Switzerland (2)
  • Show 6 more
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
48M
Group Appearance index
0.97
Avg. company exit year
12
Avg. multiplicator
2.05
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Abionyx Pharma 25 Jul 2010 Biotechnology, Health Care Late Stage Venture 59M Midi-Pyrenees, Balma, France
audiobridge 13 May 2020 Mobile, Music, iOS, Audio Seed 68K United States, California, Oakland
Morphics Technology 29 Jan 2001 Intellectual Property, Wireless, DSP, Communications Infrastructure Late Stage Venture 44M United States, California

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.